The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community - Trial NCT06118671
Access comprehensive clinical trial information for NCT06118671 through Pure Global AI's free database. This phase not specified trial is sponsored by Chongqing Medical University and is currently Not yet recruiting. The study focuses on Diabetes. Target enrollment is 460 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chongqing Medical University
Timeline & Enrollment
N/A
Nov 07, 2023
Nov 07, 2024
Primary Outcome
Change of HbA1c
Summary
The goal of this clinical trial is to learn about the application and effectiveness
 evaluation of artificial intelligence (AI) in lifestyle management of diabetic patients in
 community.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06118671
Non-Device Trial